Not yet recruitingObservationalLast updated Aug 7, 2026

HISTOACRYL® Used for Embolization of Thoracoabdominal Artery Bleeding

Observational, Prospective, Multicenter Study on HISTOACRYL® Used for Embolization of Thoracoabdominal Artery Bleeding (TAB)

Overview

ClinicalTrials.gov ID: NCT07753005
Lead Sponsor: Aesculap AGINDUSTRY
Brief Summary: This observational study will collect information from adult patients in Japan who are treated with Histoacryl® to stop bleeding from arteries in the chest or abdomen, in order to better understand how well the treatment works and how safe it is during routine medical care.
Study Type: Observational

Status

Study Record Dates

NCT05364502Active, not recruiting

(HALT) Embrace Hydrogel Embolic System (HES) Study of Embolization in Peripheral Arterial Bleeds

NCT06301919Completed

Use of N-Butyl Cyanoacrylate in Transarterial Emergency Embolization

NCT02416830Unknown status

Worldwide Therapeutic Embolization Cohort Post Market Registry

NCT01677624Completed

A Multicenter, Open-label Study for E7040 in Japanese Subjects With Hypervascular Tumor and Subjects With Arteriovenous Malformation

NCT04090320Completed

CATERPILLAR™ Arterial Embolization Device Study

NCT01902459Completed

EVARREST™ Fibrin Sealant Patch Post-Market Study